共 50 条
- [21] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer LANCET ONCOLOGY, 2018, 19 (08): : E371 - E371
- [23] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements Annals of Nuclear Medicine, 2021, 35 : 861 - 870
- [25] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
- [28] Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer LANCET ONCOLOGY, 2024, 25 (05): : 531 - 533
- [30] Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3765 - 3776